Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Merck Expects to Garner 25% of its Revenues in China by 2013

publication date: Mar 29, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck plans to increase its China sales over the next two years to the point where they contribute 25% of the company’s overall revenues, according to Merck’s new CEO, Kenneth Frazier. The company was the fastest growing of any multinational pharma during Q4 in China in terms of the number of units sold, Frazier said. More details....

Stock Symbol: (NYSE: MRK)     Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...